Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04649060
Title Study of Melphalan Flufenamide (Melflufen) in Combination With Daratumumab in Relapsed Refractory Multiple Myeloma (LIGHTHOUSE)
Acronym LIGHTHOUSE
Recruitment Terminated
Gender both
Phase Phase III
Variant Requirements No
Sponsors Oncopeptides AB
Indications
Therapies
Age Groups: senior | adult
Covered Countries POL | NOR | GRC | ESP | DEU | CZE | BGR

Facility Status City State Zip Country Details
University Multiprofile Hospital for Active Treatment "Sveti Georgi", Plovdiv, Clinical Hematology Clinic Plovdiv Bulgaria Details
Specialized Hospital for Active Treatment of Hematological Diseases, Clinical Hematology Clinic Sofia Bulgaria Details
University Hospital Brno, Clinic of Internal Medicine - Hematology and Oncology Brno 62500 Czechia Details
University Hospital Hradec Kralove, 4th Internal Clinic of Hematology Kralovice Czechia Details
University Hospital Ostrava, Clinic of Hematooncology Ostrava-Poruba Czechia Details
General University Hospital in Prague, 1st Internal Clinic - Clinic of Hematology Prague Czechia Details
JSC K. Eristavi National Center of Experimental and Clinical Surgery Tbilisi Georgia Details
Malkhaz Katsiashvili Multiprofile EMC LTD Tbilisi Georgia Details
St. Marien-Hospital Siegen gem. GmbH, Clinic for Hematology, Medical Oncology and Palliative Medicine Siegen Germany Details
Alexandra General Hospital, Therapeutic Clinic Athens Greece Details
General Hospital of Athens "Evangelismos", Department of Hematology and Lymphoma Athens Greece Details
Oslo University Hospital, Ulleval University Hospital, Oslo Myeloma Center Oslo Norway Details
Independent Public Healthcare Facility Municipal Hospitals, Teaching Department of Hematology And Prevention of Neoplastic Diseases Chorzów Poland Details
University Clinical Center, Teaching Department of Hematology and Transplantology Gdańsk Poland Details
Independent Public Healthcare Facility University Hospital in Krakow, Teaching Unit of the Hematology Department Kraków Poland Details
Nicolaus Copernicus Provincial Multispecialty Oncology and Traumatology Center in Lodz Lodz Poland Details
St. John of Dukla Oncology Center of Lublin Region, Department of Hematology and Bone Marrow Transplantation Lublin Poland Details
Leningrad Regional Clinical Hospital Saint Petersburg Russian Federation Details
V.D. Seredavin Samara Regional Clinical Hospital Samara Russian Federation Details
Clinical Center of Serbia Belgrade Serbia Details
Hospital Clinic of Barcelona, Department of Hematology Barcelona Spain Details
Cherkasy Regional Oncology Dispensary, Regional Treatment and Diagnostic Hematology Center Cherkasy Ukraine Details
Chernihiv Medical Center of Modern Oncology, Hematology Department Chernihiv Ukraine Details
City Clinical Hospital No. 4 City Hematology Center Dnipro Ukraine Details
Kyiv City Clinical Hospital No. 9, Hematology Department No. 1 Kyiv Ukraine Details
National Institute of Cancer, Research Department of Hemoblastosis Chemotherapy and Adjuvant Treatment Methods, Department of Oncohematology with Adjuvant Treatment Methods Group Kyiv Ukraine Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field